Dear all,
Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.
EASD Annual Meeting - Profil's contributions to the scientific sessions
Last week our team joined an exciting and busy 54th EASD Annual Meeting in Berlin. Profil contributed 7 posters and 4 oral presentations to the scientific sessions. The main topics are nasal glucagon, ultra rapid insulins (Ultra rapid lispro (URLi); BioChaperone Lispro), mixed insulin (BioChaperone Combo) and dual GLP-1/Glucagon receptor agonist (MEDI0382). Read more about those orals and posters presenting results from clinical trails Profil had been involved in.
EU-funded R&D partnerships in healthy living and active ageing
In our last online seminar Prof. Dr. Freimut Schliess and Jakob Haardt gave insights on EU-funded partnerships. Watching the online seminar will give you an overview of existing funding opportunities, explain how to participate in EU-funded project consortia and its opportunities for innovators and show experience in setting up new collaboration schemes and coordinating innovation consortia of partners from industry, research and academia. Watch the on-demand online seminar.
Targeting the incretin/glucagon system: a glimmer of hope
A further hope in treatment of diabetes mellitus typ 2 by targeting the incretin/glucagon system. Dual- and multi-receptor agonists may be a novel drug class to treat obesity and type 2 diabetes mellitus with high efficacy. Read about the scientific post in our diabetes blog.
Profil recently published a study on artificial pancreas systems for people with type 2 diabetes
People with diabetes perceive a high need for the availability of Artificial Pancreas systems (APS) for automated insulin delivery in diabetes care. Merging the best of different innovation cultures may contribute to a wider and more rapid implementation of user-centered APS in diabetes care. Read our publication on artificial pancreas systems for people with type 2 diabetes. You may also read our blog post concerning this study.
Meet us at upcoming conferences
Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to schedule a meeting and tell you more about our expertise!
Upcoming events: BIO-Europe in Copenhagen (11/5-7/2018), PCT 2018 in Barcelona (11/28-29/2018)
We wish you a good week and look forward to the next "Profil World",
Dr Lars Bochmann - Director Scientific Communication, Profil